Local Analgesia in Knee- and Hipatroplastic Surgery in Patients With Rheumatic Disease: Extra- vs. Intracapsulare Position of Catheter

Not Applicable

• Conditions: Rheumatoid Arthritis; Orthopedic Surgery; Analgesia
• Interventions: Procedure: Position of catheter

• Registration Number: NCT01050738
• Lead Sponsor: Spenshult Hospital

Brief Summary

Postoperative pain is part of surgery trauma. In orthopedic surgery artroplastic replacement of knee- and hipjoints are common. Postoperative pain relieve can be complicated. A new concept for pain relieve postoperative is local infiltration analgesia (LIA). This technique implicates that a catheter is left in the surgical area and that local anestesia can be administered post surgery. The goal is no or only little pain with minimal side effects. The catheter could be placed intra- or extracapsulare. The best position is not known. Primary aim is to study if position of the catheter effects the need of other postoperative analgesia. Secondary aim is to study if the position effects patient mobility within the first two days.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-01
• Study First Submitted: 2010-01-14
• Study First Submitted QC: 2010-01-14
• Study First Posted: 2010-01-15
• Status Verified: 2010-08
• Primary Completion: 2010-08
• Study Completion: 2010-08
• Last Update Submitted: 2010-08-17
• Last Update Posted: 2010-08-18

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

• Patients undergoing arthroplastic surgery of knee or hip

Exclusion Criteria

• Sensitivity to local anesthetics
• Other reason not to use local anesthetics

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intracapsulare position	Position of catheter	-
Extracapsulare position	Position of catheter	-

Primary Outcome Measures

Name	Time	Method
Need for other postoperative analgesia.	48 hours

Secondary Outcome Measures

Name	Time	Method
Patient mobility within the first 48 hours.	48 hours

Trial Locations

Locations (1)

Spenshult Hospital; 🇸🇪 Oskarström, Sweden